Significant Insider buy of BIOLASE (BIOL) Shares Breaks neutral Trend of Last Quarter

Wednesday, December 06, 2017 10:15 PM ET

Significant Insider buy of BIOLASE (BIOL) Shares Breaks neutral Trend of Last Quarter

There was significant buying activity in BIOLASE shares by an insider today, as revealed in a form 4 document filed with the SEC. One insider — Larry N Feinberg, 10% Owner — acquired 12,545,615 shares in the company having a market value of approximately $5,440,000. This is the first insider buy/sell trade in the past 90 days.

The level of buy-sell trading at BIOLASE is near the 90 member peer company average. The Advanced Medical Equipment & Technology peer group saw 99 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares per buy/sell trade transacted by BIOLASE insiders is higher. Within the peer group there were 2,543,107 shares purchased and 3,255,422 shares sold with company insiders disposing of 7,195 shares on average.

Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data sourced in creating and writing this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.